<DOC>
	<DOCNO>NCT01601158</DOCNO>
	<brief_summary>This open-label study aim evaluate safety efficacy umbilical cord blood therapy child global developmental delay .</brief_summary>
	<brief_title>Umbilical Cord Blood Therapy Children With Global Developmental Delay</brief_title>
	<detailed_description>Global developmental delay ( GDD ) subset developmental disability define significant delay two follow developmental domain : gross/fine motor , speech/language , cognition , social/personal , activity daily live . Umbilical cord blood use inherited metabolic disease feature global developmental delay many experimental animal study reveal umbilical cord blood useful repair neurological impairment brain .</detailed_description>
	<criteria>Global developmental delay Willing comply study procedure Medical instability include pneumonia renal function enrollment Poor cooperation guardian , include inactive attitude rehabilitation visit followup Uncontrolled persistent epilepsy Not eligible accord principal investigator</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Global developmental delay</keyword>
	<keyword>Umbilical cord blood</keyword>
	<keyword>Rehabilitation</keyword>
</DOC>